Global mRNA Vaccine And Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 317277
  • calendar_today Published On: Jul, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The mRNA Vaccine And Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global mRNA Vaccine And Therapeutics market size is estimated to be worth US$ 37740 million in 2021 and is forecast to a readjusted size of USD 14090 million by 2028 with a CAGR of -13.1% during review period. Hospital accounting for % of the mRNA Vaccine And Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Infectious Disease segment is altered to a % CAGR between 2022 and 2028.

Global key companies of mRNA Vaccine And Therapeutics include Argos Therapeutics, BioNTech, CureVac, eTheRNA, and Ethris, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

mRNA Vaccine And Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Infectious Disease

Cancer

Others

Market segment by Application, can be divided into

Hospital

Research Institual

Market segment by players, this report covers

Argos Therapeutics

BioNTech

CureVac

eTheRNA

Ethris

In-Cell-Art

Moderna Therapeutics

Sangamo Therapeutics

Tiba Biotechnology

Translate Bio

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe mRNA Vaccine And Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of mRNA Vaccine And Therapeutics, with revenue, gross margin and global market share of mRNA Vaccine And Therapeutics from 2019 to 2022.

Chapter 3, the mRNA Vaccine And Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and mRNA Vaccine And Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe mRNA Vaccine And Therapeutics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of mRNA Vaccine And Therapeutics

1.2 Classification of mRNA Vaccine And Therapeutics by Type

1.2.1 Overview: Global mRNA Vaccine And Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Type in 2021

1.2.3 Infectious Disease

1.2.4 Cancer

1.2.5 Others

1.3 Global mRNA Vaccine And Therapeutics Market by Application

1.3.1 Overview: Global mRNA Vaccine And Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital

1.3.3 Research Institual

1.4 Global mRNA Vaccine And Therapeutics Market Size & Forecast

1.5 Global mRNA Vaccine And Therapeutics Market Size and Forecast by Region

1.5.1 Global mRNA Vaccine And Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global mRNA Vaccine And Therapeutics Market Size by Region, (2017-2022)

1.5.3 North America mRNA Vaccine And Therapeutics Market Size and Prospect (2017-2028)

1.5.4 Europe mRNA Vaccine And Therapeutics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific mRNA Vaccine And Therapeutics Market Size and Prospect (2017-2028)

1.5.6 South America mRNA Vaccine And Therapeutics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa mRNA Vaccine And Therapeutics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 mRNA Vaccine And Therapeutics Market Drivers

1.6.2 mRNA Vaccine And Therapeutics Market Restraints

1.6.3 mRNA Vaccine And Therapeutics Trends Analysis

2 Company Profiles

2.1 Argos Therapeutics

2.1.1 Argos Therapeutics Details

2.1.2 Argos Therapeutics Major Business

2.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Product and Solutions

2.1.4 Argos Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Argos Therapeutics Recent Developments and Future Plans

2.2 BioNTech

2.2.1 BioNTech Details

2.2.2 BioNTech Major Business

2.2.3 BioNTech mRNA Vaccine And Therapeutics Product and Solutions

2.2.4 BioNTech mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 BioNTech Recent Developments and Future Plans

2.3 CureVac

2.3.1 CureVac Details

2.3.2 CureVac Major Business

2.3.3 CureVac mRNA Vaccine And Therapeutics Product and Solutions

2.3.4 CureVac mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 CureVac Recent Developments and Future Plans

2.4 eTheRNA

2.4.1 eTheRNA Details

2.4.2 eTheRNA Major Business

2.4.3 eTheRNA mRNA Vaccine And Therapeutics Product and Solutions

2.4.4 eTheRNA mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 eTheRNA Recent Developments and Future Plans

2.5 Ethris

2.5.1 Ethris Details

2.5.2 Ethris Major Business

2.5.3 Ethris mRNA Vaccine And Therapeutics Product and Solutions

2.5.4 Ethris mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Ethris Recent Developments and Future Plans

2.6 In-Cell-Art

2.6.1 In-Cell-Art Details

2.6.2 In-Cell-Art Major Business

2.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Product and Solutions

2.6.4 In-Cell-Art mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 In-Cell-Art Recent Developments and Future Plans

2.7 Moderna Therapeutics

2.7.1 Moderna Therapeutics Details

2.7.2 Moderna Therapeutics Major Business

2.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Product and Solutions

2.7.4 Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Moderna Therapeutics Recent Developments and Future Plans

2.8 Sangamo Therapeutics

2.8.1 Sangamo Therapeutics Details

2.8.2 Sangamo Therapeutics Major Business

2.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Product and Solutions

2.8.4 Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Sangamo Therapeutics Recent Developments and Future Plans

2.9 Tiba Biotechnology

2.9.1 Tiba Biotechnology Details

2.9.2 Tiba Biotechnology Major Business

2.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Product and Solutions

2.9.4 Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Tiba Biotechnology Recent Developments and Future Plans

2.10 Translate Bio

2.10.1 Translate Bio Details

2.10.2 Translate Bio Major Business

2.10.3 Translate Bio mRNA Vaccine And Therapeutics Product and Solutions

2.10.4 Translate Bio mRNA Vaccine And Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Translate Bio Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global mRNA Vaccine And Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 mRNA Vaccine And Therapeutics Players Market Share in 2021

3.2.2 Top 10 mRNA Vaccine And Therapeutics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 mRNA Vaccine And Therapeutics Players Head Office, Products and Services Provided

3.4 mRNA Vaccine And Therapeutics Mergers & Acquisitions

3.5 mRNA Vaccine And Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global mRNA Vaccine And Therapeutics Revenue and Market Share by Type (2017-2022)

4.2 Global mRNA Vaccine And Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2017-2022)

5.2 Global mRNA Vaccine And Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America mRNA Vaccine And Therapeutics Revenue by Type (2017-2028)

6.2 North America mRNA Vaccine And Therapeutics Revenue by Application (2017-2028)

6.3 North America mRNA Vaccine And Therapeutics Market Size by Country

6.3.1 North America mRNA Vaccine And Therapeutics Revenue by Country (2017-2028)

6.3.2 United States mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

6.3.3 Canada mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

6.3.4 Mexico mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe mRNA Vaccine And Therapeutics Revenue by Type (2017-2028)

7.2 Europe mRNA Vaccine And Therapeutics Revenue by Application (2017-2028)

7.3 Europe mRNA Vaccine And Therapeutics Market Size by Country

7.3.1 Europe mRNA Vaccine And Therapeutics Revenue by Country (2017-2028)

7.3.2 Germany mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

7.3.3 France mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

7.3.5 Russia mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

7.3.6 Italy mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Type (2017-2028)

8.2 Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Application (2017-2028)

8.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region

8.3.1 Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Region (2017-2028)

8.3.2 China mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

8.3.3 Japan mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

8.3.4 South Korea mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

8.3.5 India mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

8.3.7 Australia mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America mRNA Vaccine And Therapeutics Revenue by Type (2017-2028)

9.2 South America mRNA Vaccine And Therapeutics Revenue by Application (2017-2028)

9.3 South America mRNA Vaccine And Therapeutics Market Size by Country

9.3.1 South America mRNA Vaccine And Therapeutics Revenue by Country (2017-2028)

9.3.2 Brazil mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

9.3.3 Argentina mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa mRNA Vaccine And Therapeutics Revenue by Type (2017-2028)

10.2 Middle East & Africa mRNA Vaccine And Therapeutics Revenue by Application (2017-2028)

10.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country

10.3.1 Middle East & Africa mRNA Vaccine And Therapeutics Revenue by Country (2017-2028)

10.3.2 Turkey mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

10.3.4 UAE mRNA Vaccine And Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global mRNA Vaccine And Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global mRNA Vaccine And Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market mRNA Vaccine And Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global mRNA Vaccine And Therapeutics Revenue (USD Million) by Region (2017-2022)

Table 5. Global mRNA Vaccine And Therapeutics Revenue Market Share by Region (2023-2028)

Table 6. Argos Therapeutics Corporate Information, Head Office, and Major Competitors

Table 7. Argos Therapeutics Major Business

Table 8. Argos Therapeutics mRNA Vaccine And Therapeutics Product and Solutions

Table 9. Argos Therapeutics mRNA Vaccine And Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. BioNTech Corporate Information, Head Office, and Major Competitors

Table 11. BioNTech Major Business

Table 12. BioNTech mRNA Vaccine And Therapeutics Product and Solutions

Table 13. BioNTech mRNA Vaccine And Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. CureVac Corporate Information, Head Office, and Major Competitors

Table 15. CureVac Major Business

Table 16. CureVac mRNA Vaccine And Therapeutics Product and Solutions

Table 17. CureVac mRNA Vaccine And Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. eTheRNA Corporate Information, Head Office, and Major Competitors

Table 19. eTheRNA Major Business

Table 20. eTheRNA mRNA Vaccine And Therapeutics Product and Solutions

Table 21. eTheRNA mRNA Vaccine And Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Ethris Corporate Information, Head Office, and Major Competitors

Table 23. Ethris Major Business

Table 24. Ethris mRNA Vaccine And Therapeutics Product and Solutions

Table 25. Ethris mRNA Vaccine And Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. In-Cell-Art Corporate Information, Head Office, and Major Competitors

Table 27. In-Cell-Art Major Business

Table 28. In-Cell-Art mRNA Vaccine And Therapeutics Product and Solutions

Table 29. In-Cell-Art mRNA Vaccine And Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Moderna Therapeutics Corporate Information, Head Office, and Major Competitors

Table 31. Moderna Therapeutics Major Business

Table 32. Moderna Therapeutics mRNA Vaccine And Therapeutics Product and Solutions

Table 33. Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Sangamo Therapeutics Corporate Information, Head Office, and Major Competitors

Table 35. Sangamo Therapeutics Major Business

Table 36. Sangamo Therapeutics mRNA Vaccine And Therapeutics Product and Solutions

Table 37. Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Tiba Biotechnology Corporate Information, Head Office, and Major Competitors

Table 39. Tiba Biotechnology Major Business

Table 40. Tiba Biotechnology mRNA Vaccine And Therapeutics Product and Solutions

Table 41. Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Translate Bio Corporate Information, Head Office, and Major Competitors

Table 43. Translate Bio Major Business

Table 44. Translate Bio mRNA Vaccine And Therapeutics Product and Solutions

Table 45. Translate Bio mRNA Vaccine And Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global mRNA Vaccine And Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global mRNA Vaccine And Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of mRNA Vaccine And Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. mRNA Vaccine And Therapeutics Players Head Office, Products and Services Provided

Table 50. mRNA Vaccine And Therapeutics Mergers & Acquisitions in the Past Five Years

Table 51. mRNA Vaccine And Therapeutics New Entrants and Expansion Plans

Table 52. Global mRNA Vaccine And Therapeutics Revenue (USD Million) by Type (2017-2022)

Table 53. Global mRNA Vaccine And Therapeutics Revenue Share by Type (2017-2022)

Table 54. Global mRNA Vaccine And Therapeutics Revenue Forecast by Type (2023-2028)

Table 55. Global mRNA Vaccine And Therapeutics Revenue by Application (2017-2022)

Table 56. Global mRNA Vaccine And Therapeutics Revenue Forecast by Application (2023-2028)

Table 57. North America mRNA Vaccine And Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 58. North America mRNA Vaccine And Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 59. North America mRNA Vaccine And Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 60. North America mRNA Vaccine And Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 61. North America mRNA Vaccine And Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 62. North America mRNA Vaccine And Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe mRNA Vaccine And Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe mRNA Vaccine And Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe mRNA Vaccine And Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe mRNA Vaccine And Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe mRNA Vaccine And Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe mRNA Vaccine And Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific mRNA Vaccine And Therapeutics Revenue by Region (2023-2028) & (USD Million)

Table 75. South America mRNA Vaccine And Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 76. South America mRNA Vaccine And Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 77. South America mRNA Vaccine And Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 78. South America mRNA Vaccine And Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 79. South America mRNA Vaccine And Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 80. South America mRNA Vaccine And Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa mRNA Vaccine And Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa mRNA Vaccine And Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa mRNA Vaccine And Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa mRNA Vaccine And Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa mRNA Vaccine And Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa mRNA Vaccine And Therapeutics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. mRNA Vaccine And Therapeutics Picture

Figure 2. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type in 2021

Figure 3. Infectious Disease

Figure 4. Cancer

Figure 5. Others

Figure 6. mRNA Vaccine And Therapeutics Revenue Market Share by Application in 2021

Figure 7. Hospital Picture

Figure 8. Research Institual Picture

Figure 9. Global mRNA Vaccine And Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global mRNA Vaccine And Therapeutics Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global mRNA Vaccine And Therapeutics Revenue Market Share by Region (2017-2028)

Figure 12. Global mRNA Vaccine And Therapeutics Revenue Market Share by Region in 2021

Figure 13. North America mRNA Vaccine And Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe mRNA Vaccine And Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific mRNA Vaccine And Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America mRNA Vaccine And Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa mRNA Vaccine And Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. mRNA Vaccine And Therapeutics Market Drivers

Figure 19. mRNA Vaccine And Therapeutics Market Restraints

Figure 20. mRNA Vaccine And Therapeutics Market Trends

Figure 21. Argos Therapeutics Recent Developments and Future Plans

Figure 22. BioNTech Recent Developments and Future Plans

Figure 23. CureVac Recent Developments and Future Plans

Figure 24. eTheRNA Recent Developments and Future Plans

Figure 25. Ethris Recent Developments and Future Plans

Figure 26. In-Cell-Art Recent Developments and Future Plans

Figure 27. Moderna Therapeutics Recent Developments and Future Plans

Figure 28. Sangamo Therapeutics Recent Developments and Future Plans

Figure 29. Tiba Biotechnology Recent Developments and Future Plans

Figure 30. Translate Bio Recent Developments and Future Plans

Figure 31. Global mRNA Vaccine And Therapeutics Revenue Share by Players in 2021

Figure 32. mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 33. Global Top 3 Players mRNA Vaccine And Therapeutics Revenue Market Share in 2021

Figure 34. Global Top 10 Players mRNA Vaccine And Therapeutics Revenue Market Share in 2021

Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 36. Global mRNA Vaccine And Therapeutics Revenue Share by Type in 2021

Figure 37. Global mRNA Vaccine And Therapeutics Market Share Forecast by Type (2023-2028)

Figure 38. Global mRNA Vaccine And Therapeutics Revenue Share by Application in 2021

Figure 39. Global mRNA Vaccine And Therapeutics Market Share Forecast by Application (2023-2028)

Figure 40. North America mRNA Vaccine And Therapeutics Sales Market Share by Type (2017-2028)

Figure 41. North America mRNA Vaccine And Therapeutics Sales Market Share by Application (2017-2028)

Figure 42. North America mRNA Vaccine And Therapeutics Revenue Market Share by Country (2017-2028)

Figure 43. United States mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Canada mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Mexico mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Europe mRNA Vaccine And Therapeutics Sales Market Share by Type (2017-2028)

Figure 47. Europe mRNA Vaccine And Therapeutics Sales Market Share by Application (2017-2028)

Figure 48. Europe mRNA Vaccine And Therapeutics Revenue Market Share by Country (2017-2028)

Figure 49. Germany mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. France mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. United Kingdom mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Russia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Italy mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Asia-Pacific mRNA Vaccine And Therapeutics Sales Market Share by Type (2017-2028)

Figure 55. Asia-Pacific mRNA Vaccine And Therapeutics Sales Market Share by Application (2017-2028)

Figure 56. Asia-Pacific mRNA Vaccine And Therapeutics Revenue Market Share by Region (2017-2028)

Figure 57. China mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Japan mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. South Korea mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. India mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Southeast Asia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Australia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South America mRNA Vaccine And Therapeutics Sales Market Share by Type (2017-2028)

Figure 64. South America mRNA Vaccine And Therapeutics Sales Market Share by Application (2017-2028)

Figure 65. South America mRNA Vaccine And Therapeutics Revenue Market Share by Country (2017-2028)

Figure 66. Brazil mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Argentina mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Middle East and Africa mRNA Vaccine And Therapeutics Sales Market Share by Type (2017-2028)

Figure 69. Middle East and Africa mRNA Vaccine And Therapeutics Sales Market Share by Application (2017-2028)

Figure 70. Middle East and Africa mRNA Vaccine And Therapeutics Revenue Market Share by Country (2017-2028)

Figure 71. Turkey mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Saudi Arabia mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. UAE mRNA Vaccine And Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Methodology

Figure 75. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz